NCT01904747
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Clinical trial condition
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
NCT01904747
NCT01285544
NCT01138371
NCT01624207
NCT02011789
NCT00000471
Not specified
NCT01979601
NCT01133210
NCT00001137
NCT00074971